In RCC, several studies suggested that PD-L1 positivity is associated with a high number of tumor-infiltrating lymphocytes [13–20] and poor prognosis in cancers treated otherwise [15, 17, 19, 21–32]. The gene discussed is CD274; the disease is neoplasm.